ARCHIVES

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011